Clinical Trials List
2025-05-09 - 2030-07-15
Phase III
Recruiting2
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- 蕭慈慧 Division of Thoracic Medicine
- 廖映庭 Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Hui Lee Division of Hematology & Oncology
- 林建佑 Division of General Internal Medicine
- 蔡政軒 Division of General Internal Medicine
- Wu-Chou Su Division of Hematology & Oncology
- Seu-Chun Yang Division of General Internal Medicine
- Chian-Wei Chen Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
- Chin-Wei Kuo Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
330 participants
